Erste Asset Management Gmb H Biotechnology

Erste Asset Management Gmb H

$11.9 Trillion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
FOLD Amicus Therapeutics, Inc.	$1.96B	$693 Million 0.01% of portfolio	116,850	Q2 2022 Added 86.66%
RARE Ultragenyx Pharmaceutical Inc.	$1.97B	$636 Million 0.01% of portfolio	17,421	Q2 2025 Added 16.06%
JANX Janux Therapeutics, Inc.	$1.01B	$625 Million 0.01% of portfolio	27,000	Q1 2025 New
ZLAB Zai Lab LTD	$3.36B	$525 Million 0.0% of portfolio	15,100	Q4 2021 Reduced 27.81%
LGND Ligand Pharmaceuticals Inc	$2.58B	$491 Million 0.0% of portfolio	4,300	Q2 2022 Reduced 40.28%
EYPT Eye Point Pharmaceuticals, Inc.	$366M	$482 Million 0.0% of portfolio	50,000	Q4 2024 New
VCYT Veracyte, Inc.	$2.06B	$465 Million 0.0% of portfolio	17,000	Q3 2024 New
AUTL Autolus Therapeutics PLC	$195M	$450 Million 0.0% of portfolio	195,000	Q1 2023 Added 62.5%
ADPT Adaptive Biotechnologies Corp	$1.81B	$421 Million 0.0% of portfolio	35,700	Q4 2020 Reduced 15.0%
HRMY Harmony Biosciences Holdings, Inc.	$2.1B	$419 Million 0.0% of portfolio	13,100	Q3 2024 New
IBRX Immunity Bio, Inc.	$989M	$413 Million 0.0% of portfolio	153,000	Q3 2024 New
GLPG Galapagos Nv	$2.09B	$392 Million 0.0% of portfolio	14,000	Q1 2022 Sold Out
DNLI Denali Therapeutics Inc.	$1.77B	$379 Million 0.0% of portfolio	26,900	Q4 2023 Reduced 91.96%
BCRX Biocryst Pharmaceuticals Inc	$1.55B	$374 Million 0.0% of portfolio	40,000	Q3 2024 New
BEAM Beam Therapeutics Inc.	$1.19B	$365 Million 0.0% of portfolio	21,700	Q4 2022 Added 45.64%
DAWN Day One Biopharmaceuticals, Inc.	$451M	$331 Million 0.0% of portfolio	51,200	Q3 2024 New
KROS Keros Therapeutics, Inc.	$353M	$279 Million 0.0% of portfolio	20,700	Q3 2022 Reduced 72.46%
SAGE Sage Therapeutics, Inc.	$516M	$261 Million 0.0% of portfolio	28,500	Q2 2022 Reduced 19.72%
ABCL Ab Cellera Biologics Inc.	$1.22B	$224 Million 0.0% of portfolio	62,000	Q3 2024 New
RXRX Recursion Pharmaceuticals, Inc.	$976M	$169 Million 0.0% of portfolio	33,500	Q3 2024 New
VIR Vir Biotechnology, Inc.	$578M	$149 Million 0.0% of portfolio	28,800	Q4 2021 Added 15.63%
RCKT Rocket Pharmaceuticals, Inc.	$220M	$113 Million 0.0% of portfolio	44,700	Q3 2022 Reduced 62.64%
SANA Sana Biotechnology, Inc.	$592M	$112 Million 0.0% of portfolio	40,000	Q3 2024 New
REPL Replimune Group, Inc.	$259M	$111 Million 0.0% of portfolio	11,900	Q3 2024 New
RGNX Regenxbio Inc.	$350M	$109 Million 0.0% of portfolio	13,000	Q3 2024 New
BCYC Bicycle Therapeutics PLC	$214M	$101 Million 0.0% of portfolio	14,000	Q3 2024 New
RLAY Relay Therapeutics, Inc.	$403M	$76.2 Million 0.0% of portfolio	23,100	Q3 2024 New
MRVI Maravai Lifesciences Holdings, Inc.	$354M	$70.1 Million 0.0% of portfolio	28,400	Q3 2024 New
ALLO Allogene Therapeutics, Inc.	$148M	$37.1 Million 0.0% of portfolio	31,400	Q4 2021 Added 29.94%
ALEC Alector, Inc.	$165M	$28.1 Million 0.0% of portfolio	19,000	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.